l carnitine arterial plaque Abstract 4142959: Carotid 3D Composition after Supplementation in Patients with Metabolic Syndrome Plaque: Define Supplement That May
Description
Halkos, S.M

Because its derived from EPO, a central concern was unintended stimulation of red blood cell production or thrombosis risk, but trials so far suggest negligible erythropoietic activity at therapeutic doses

[PMC free article: PMC4646036] [PubMed: 26424796] 60
B.KemnitzJ
